Wendolyn Carlos Alcalde: Platelets in the Tumor Microenvironment
Wendolyn Carlos Alcalde, Biochemistry and Cell Biology PhD Candidate at Rice University, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in Blood Vessels, Thrombosis and Hemostasis, adding:
“I am excited to share a new publication from my time at UT MD Anderson Cancer Center!
During my 4 years in the lab, I had the opportunity to collaborate with an incredible group of scientists on a variety of research efforts.
I am thrilled to see one of these projects, ‘Molecular Control of Platelet Extravasation into Tumors and Its Impact on Tumor Growth,’ officially published in Blood Vessels, Thrombosis and Hemostasis.
This was a fantastic team effort to decode the complex role platelets play in the tumor microenvironment. Here are a few key highlights from the paper:
Molecular Drivers and Therapeutic Targets: CXCL12-CXCR4, focal adhesion kinase, and platelet endothelial cell adhesion molecule 1 govern platelet extravasation.
Crucially, we demonstrated that CXCR4 blockade reduces both platelet infiltration and tumor burden.
Divergent Granule Functions: We found that dense and α-granule secretions diverge in function: one promotes tumor growth, whereas the other maintains vascular integrity.”
Title: Molecular control of platelet extravasation into tumors and its impact on tumor growth
Authors: Hani Lee, Wendolyn Carlos Alcalde, Ricardo Gonzalez Delgado, Ju Young Ahn, Matthew Vasquez, Min Soon Cho, Stephen T C Wong, Anil K Sood, Vahid Afshar-Kharghan

Stay updated with Hemostasis Today.
-
Nov 11, 2026, 15:42Tareq Abadl: The Clinical Impact of Kell Alloimmunization
-
Nov 11, 2026, 15:30Alejandro González Veliz: Does PCI Change The Long-Term Outcome In Stable Coronary Artery Disease?
-
Nov 11, 2026, 15:25Preparing for the SoHO Regulation – EBA Board Convenes in Vienna – European Blood Alliance
-
Nov 11, 2026, 15:20Vaidehi Prasanth: IV Iron in Heart Failure – Exploring Hospitalisation Benefits vs. Infection Risk in Open Heart
-
Nov 11, 2026, 15:18Stefan Prendić: Can Algorithms Support Antibody Identification in Immunohematology?
-
Nov 11, 2026, 15:12Perioperative Challenges in Hemophilia Patients on Rebalancing Therapies
-
Nov 11, 2026, 15:03Maria Elisa Mancuso: World-Renowned Faculty and 33 Global Participants Unite at Hemophilia Academy 2026
-
Nov 11, 2026, 15:01Hassan Raza: The JAK2 V617F Revolution
-
Nov 11, 2026, 14:57Edward Lee Carter: Factor Xla Inhibition Enters Clinical Practice – FDA Approval of Asundexian